Shanghai Zhiyu Biotechnology Co.
Latest round
- Series A
Last raised
- May 2023
Total raised
- $14M
Investors
- 6
About Shanghai Zhiyu Biotechnology Co.
Established in 2021 and based in Shanghai, China, The company has built a complete protein structure prediction, design, and production system on its own to carry out drug-assisted R&D and synthetic biology business. Dr. Sheng Wang, CEO of the company, is a top global scholar in the field of artificial intelligence combined with protein research and was a senior research expert at Tencent AI Lab. Doctors from the Chinese Academy of Sciences, CSU, and other research institutions jointly participate in the company's team project development, in addition to academic research support and cooperation support from academic leaders from the University of Hong Kong-China, Fudan, and Chinese Academy of Sciences. The company has built a service platform for protein structure prediction and design and related applications, including single-sequence protein structure prediction, multi-sequence protein complex structure prediction, protein-ligand binding energy prediction, protein structure design, and sequence design, protein complex interaction design, protein stability modification, and other services. Based on big data and AI protein structure prediction and protein-ligand binding energy calculation and optimization, the company has completed 30W+ protein structure prediction and R&D assistance services for nearly 30 customers. Specific products include ZCloud, a protein structure prediction, and R&D aid facility; ZPod, a one-stop engineering solution for protein structure calculation and ZBot, a high-throughput automated wet experiment platform. In the future, the company's service platform will also include new services for drug development such as fully automated high-throughput virtual screening, structure-based small molecule generation, fully automated high-performance free energy perturbation, and small molecule property prediction.
Who invested in Shanghai Zhiyu Biotechnology Co.
6 investors across 2 rounds
See all investors in Shanghai Zhiyu Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Zhiyu Biotechnology Co.
Who invested in Shanghai Zhiyu Biotechnology Co.?
Shanghai Zhiyu Biotechnology Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Zhiyu Biotechnology Co. raised?
Shanghai Zhiyu Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Zhiyu Biotechnology Co. last raise money?
Shanghai Zhiyu Biotechnology Co.'s most recent round on record is a Series A, in May 2023.
What does Shanghai Zhiyu Biotechnology Co. do?
Established in 2021 and based in Shanghai, China, The company has built a complete protein structure prediction, design, and production system on its own to carry out drug-assisted R&D and synthetic biology business.
Where is Shanghai Zhiyu Biotechnology Co. headquartered?
Shanghai Zhiyu Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Zhiyu Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Zhiyu Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Zhiyu Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.